Sunday 19 April 2015
 
»
Tag
 
»
Pharmaceuticals

Takeda opens new UAE office in Dubai

Takeda UAE, a unit of Japan-based Takeda Pharmaceutical Company, has inaugurated its new UAE office, located at Tecom IRise Tower, Dubai amid ambitious expansion plans for the Middle East region. Speaking at the inauguration cerem

More…

$4bn Saudi pharma sector 'to maintain strong growth'

Saudi Arabia's pharmaceutical industry grew to $4 billion last year from $3 billion in 2008, said an industry expert, adding that the sector is expected to maintain its strong growth momentum. “However, a gradual shift t

More…

Roche names new ME sub-region head

Roche’s pharmaceuticals division has promoted Ehab Yousef to the newly created role of sub-region head for Middle East, overseeing the market activities in GCC region, Egypt and Yemen. Tthe move results from an effort by the

More…

Pfizer ends $118bn AstraZeneca takeover fight

Pfizer abandoned its attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) on Monday as a deadline approached without a last-minute change of heart by the British drugmaker. The decision ends a month-long public f

More…

AstraZeneca rejects Pfizer's new $118bn offer

Britain's AstraZeneca on Monday rejected a sweetened and "final" offer from Pfizer, casting serious doubt on the US drugmaker's plan for a merger to create the world's biggest pharmaceuticals group. The rebuf

More…

Pfizer chasing AstraZeneca in $100bn-plus deal

US drugmaker Pfizer wants to buy AstraZeneca in a deal that could value its smaller British rival at more than $100 billion, creating a new giant on the global pharmaceuticals scene. Pfizer confirmed on Monday it made a bid approa

More…

Pfizer chasing AstraZeneca in $100bn-plus deal

US drugmaker Pfizer wants to buy AstraZeneca in a deal that could value its smaller British rival at more than $100 billion, creating a new giant on the global pharmaceuticals scene. Pfizer confirmed on Monday it made a bid approa

More…

Julphar in deal to produce, market MSD drugs

MSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region.

More…

Julphar in deal to produce, market MSD drugs

MSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region.

More…

Hikma’s H1 revenue hits $523m, up 35pc

UK-based Hikma Pharmaceuticals, a fast growing global pharmaceutical group, has posted revenue of $532.3 million for the first half of the year, marking a 34.8 per cent increase over the same period last year. The group, with sales in m

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads